Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Linearis Opens New Lab in Quebec | Contract Pharma

What are you searching for?

Sign in
Breaking News

Linearis Opens New Lab in Quebec

Introduces a high-throughput metabolomics platform.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics platform, which integrates artificial intelligence (AI) to support life sciences projects to accelerate the benefits to patients.

The integration of AI and automated high-throughput analyses of approximately 1,300 metabolic biomarkers enables Linearis to provide tailored services to biobanks, clinical research groups, and biopharmaceutical companies in identifying various elements linked to metabolic diseases such as cancer, diabetes, and antimicrobial resistance, aiming to enhance prevention, screening, treatment monitoring, and the discovery of new drugs.

“The launch of our high-throughput metabolomics laboratory, combined with our investment fund, marks a pivotal step in establishing a true biohub at the intersection of AI-life sciences. This integrated model enables us to support the ecosystem better while accelerating the transformation of scientific discoveries into real-world solutions for patients,” stated Alexandre Le Bouthillier, PhD, CEO of Linearis.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters